Free
Correspondence  |   November 2009
All Glucose Measurements Are Not Equal
Author Affiliations & Notes
  • Mark J. Rice, M.D.
    *
  • *University of Florida College of Medicine, Gainesville, Florida.
Article Information
Correspondence
Correspondence   |   November 2009
All Glucose Measurements Are Not Equal
Anesthesiology 11 2009, Vol.111, 1160. doi:10.1097/ALN.0b013e3181ba3a35
Anesthesiology 11 2009, Vol.111, 1160. doi:10.1097/ALN.0b013e3181ba3a35
To the Editor:—
We read with interest the study by Bilotta et al.  1 comparing intensive insulin therapy to conventional treatment in two cohorts of neurosurgical patients. When an arterial catheter was not available for glucose determination, capillary blood was measured with the HemoCue point-of-care device (HemoCue, Angelholm, Sweden). This was a wise choice, as this system has been shown to be accurate, even at low glucose concentrations.2 What is not commonly appreciated is that most other point-of-care glucose measurement devices are not sufficiently accurate for critical care use, and that such devices originally approved and regulated for home self-monitoring by patients with diabetes have migrated into the hospital setting without further regulatory scrutiny. In fact, it has been specifically recommended that point-of-care devices designed for patient use at home, yet sometimes used in hospitals, should not be used in critically ill patients.3 
Although their use of capillary blood for glucose determination is understandable, it should be pointed out that arterial blood glucose concentrations have been demonstrated to be a better representation of plasma glucose as compared with simultaneous capillary measurements.4,5 This may be secondary to a variable time constant in the fingertip blood pool. Furthermore, hypotension, hypoxia, and acidosis, which are common problems in the critical care population, can significantly affect these capillary readings.6 
Not all glucose measurements are equivalent, and care must be taken in their interpretation, especially at low concentrations.
*University of Florida College of Medicine, Gainesville, Florida.
References
Bilotta F, Caramia R, Paoloni FP, Delfini R, Rosa G: Safety and efficacy of intensive insulin therapy in critical neurosurgical patients. Anesthesiology 2009; 110:611–9Bilotta, F Caramia, R Paoloni, FP Delfini, R Rosa, G
Stork AD, Kemperman H, Erkelens DW, Veneman TF: Comparison of the accuracy of the HemoCue glucose analyzer with the Yellow Springs Instrument glucose oxidase analyzer, particularly in hypoglycemia. Eur J Endocrinol 2005; 153:275–81Stork, AD Kemperman, H Erkelens, DW Veneman, TF
Hoedemaekers CW, Klein Gunnewiek JM, Prinsen MA, Willems JL, Van der Hoeven JG: Accuracy of bedside glucose measurement from three glucometers in critically ill patients. Crit Care Med 2008; 36:3062–6Hoedemaekers, CW Klein Gunnewiek, JM Prinsen, MA Willems, JL Van der Hoeven, JG
Kanji S, Buffie J, Hutton B, Bunting PS, Singh A, McDonald K, Fergusson D, McIntyre LA, Hebert PC: Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med 2005; 33:2778–85Kanji, S Buffie, J Hutton, B Bunting, PS Singh, A McDonald, K Fergusson, D McIntyre, LA Hebert, PC
Slater-MacLean L, Cembrowski G, Chin D, Shalapay C, Binette T, Hegadoren K, Newburn-Cook C: Accuracy of glycemic measurements in the critically ill. Diabetes Technol Ther 2008; 10:169–77Slater-MacLean, L Cembrowski, G Chin, D Shalapay, C Binette, T Hegadoren, K Newburn-Cook, C
Dungan K, Chapman J, Braithwaite SS, Buse J: Glucose measurement: Confounding issues in setting targets for inpatient management. Diabetes Care 2007; 30:403–9Dungan, K Chapman, J Braithwaite, SS Buse, J